Skip to main content
. 2014 Nov 13;125(2):236–241. doi: 10.1182/blood-2014-06-584623

Table 1.

Patient characteristics

Clinical variable S0313 (n = 46) S0014 (n = 60) S8736 (n = 68)
No. % No. % No. %
Age, y
 Median 61* 69 66
 Range 23-85 26-85 35-85
 ≥60 26 57 44 73 52 76
Male sex 30 65* 27 45 40 59
White race 43 93 57 95 63 93
Hispanic race 3 7 1 2 2 3
B symptoms 9 20 14 23 14 21
Histology
 DLBCL 44 96 56 93 60 88
 Burkitt-like 1 2 3 5 7 10
 High-grade B 0 0 1 2 1 1
 Mantle cell 1 2 0 0 0 0
LDH > ULN 15 33 13 22 17 25
Stage II 24 52 26 43 32 47
Performance status
 0 29 64 42 70 51 75
 1 14 31 17 28 15 22
 2 2 4 1 2 2 3
Stage-modified IPI risk
 1 30 65 42 70 40 59
 2 12 26 12 20 21 31
 3 3 7 6 10 7 10
 4 1 2 0 0 0 0

ULN, upper limit of normal.

*

Statistically significantly different from study S0014, P < .05.

The only case of Burkitt-like lymphoma in S0313 was reviewed and confirmed to be Burkitt lymphoma.